Discussing the Evolution of Immunotherapy in Lymphomas
Joshua Brody, MD, discusses how he sees the use of immunotherapy evolving in coming years.
Vaccine Strategies in Follicular Lymphoma
Joshua Brody, MD, assistant professor, Icahn School of Medicine, director, Lymphoma Immunotherapy Program, Mount Sinai Hospital, discusses vaccine strategies in follicular lymphoma.